Pharmaceutical Commercialization Solutions and Services Industry Research 2024-2029: Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Platforms Drive Expansion
16 oct. 2024 11h45 HE
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - SEPTEMBRE 2024
15 oct. 2024 16h05 HE
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - September 2024
15 oct. 2024 16h05 HE
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Germany Pharmaceuticals Market Report 2024-2028: Consolidation through Mergers and Acquisitions Catalyzing Growth
09 oct. 2024 06h43 HE
|
Research and Markets
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceuticals Market in Germany 2024-2028" report has been added to ResearchAndMarkets.com's offering. The pharmaceuticals sector in Germany is...
Avextra Announces the Approval of NEUROBIS by the Italian Medicines Agency: A Phase II Clinical Trial Using a Proprietary Cannabis-based Medicine for the Treatment of the Symptoms of Neurodegenerative Diseases
08 oct. 2024 07h00 HE
|
Avextra AG
The Italian Medicines Agency AIFA and the Italian Ministry of Health have granted formal approval for NEUROBIS; a multi-centre Phase II study to evaluate safety, and efficacy of an Avextra oral...
[Latest] Global Heavy Metal Testing Market Size/Share Worth USD 5.6 Billion by 2033 at a 6.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
07 oct. 2024 14h10 HE
|
Custom Market Insights
Austin, TX, USA, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Heavy Metal Testing Market Size, Trends and Insights By Type (Arsenic, Cadmium,...
Pharmaceuticals Collaboration Deals Report, 2019-2024: Assess Financials Terms, Leading Deals by Value, Most Active Dealmakers, Contract Documents & More
02 oct. 2024 12h31 HE
|
Research and Markets
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Pharmaceuticals, 2019-2024" report has been added to ResearchAndMarkets.com's offering.Collaboration Deals in Pharmaceuticals...
PharmaCorp Completes Acquisition of a Pharmacy in Atlantic Canada
02 oct. 2024 07h30 HE
|
Pharma Corp Rx Inc.
PharmaCorp completes acquisition of pharmacy in Atlantic Canada
Therapeutics (Biologics, Biosimilars, Small Molecules) Research Report 2024-2030 with Analyst Recommendations - Focus on Personalized Medicine & Targeted therapy with Nanomedicine
01 oct. 2024 06h27 HE
|
Research and Markets
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By...
Adaptive Research Announces it has Begun Enrolling Patients in AriBio’s Phase 3 POLARIS-AD Clinical Trial
30 sept. 2024 08h00 HE
|
Adaptive Research Inc
Adaptive Research announced it has begun enrolling patients in
AriBio’s Phase 3 POLARIS-AD Clinical Trial.